Insitro Secures $25 Million from Bristol Myers Squibb for ALS Target Discovery Milestones
Insitro, a machine learning-driven drug discovery and development company, announced today that it has received $25 million from Bristol Myers Squibb (NYSE: BMY) following the achievement of discovery milestones and the selection of the first novel genetic target for amyotrophic…